William Feng

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Matthew Booker

Dana-Farber Cancer Institute

UNITED STATES

View details

Jonathan Duke-Cohan

Lecturer

Boston University

UNITED STATES

View details

Manabu Kurokawa

Kent State University

UNITED STATES

View details

Tyler Beyett

Assistant Professor

Emory University

UNITED STATES

View details

David Heppner

Assistant Professor

University at Buffalo

UNITED STATES

View details

Eiji Kobayashi

Assistant professor

University of Toyama

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Feng

Research Interests

Explore related searches

Contact this professor

Articles (14)

Transferrin receptor targeting chimeras for membrane protein degradation

Parsing digital or analog TCR performance through piconewton forces

Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors

The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target

Hepatic <i>Huwe1</i> loss protects mice from non- alcoholic fatty liver disease through lipid metabolic rewiring

Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

Parsing digital or analogue TCR performance through piconewton forces

Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

CD36: a key mediator of resistance to HER2 inhibitors in breast cancer

Endocytosis of very low-density lipoproteins: An unexpected mechanism for lipid acquisition by breast cancer cells

Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer

X-Linked Huwe1 Is Essential for Oocyte Maturation and Preimplantation Embryo Development

Collaborators (6)

Matthew Booker

Jonathan Duke-Cohan

Manabu Kurokawa

Tyler Beyett

David Heppner

Eiji Kobayashi

Make your next move.